ZHENGYANG BIOMEDICAL TECHNOLOGY
Zhengyang Biomedical Technology is developing and producing cutting-edge regenerative medicine applications in medical, pharmaceutical, skincare products, and other related products, the natural multiple growth factor extraction technologies can be used in skincare products, as well as in stem cell culture and cell therapy. And has signed cell culture liquid distribution contracts and strategic cooperation.
ZHENGYANG BIOMEDICAL TECHNOLOGY
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2004-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.zybt.com.tw
Total Employee:
11+
Status:
Active
Contact:
+886 2 2995 0083
Email Addresses:
[email protected]
Technology used in webpage:
Euro SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail AJAX Libraries API Common Name Invalid HiNet
Similar Organizations
Jinglei Biotechnology
Jinglei Biotechnology provides biotechnology services.
Ningaloo Biosystems
Ningaloo Biosystems is a bio technology research center.
Sidx Biomedical Technology
Sidx Biomedical Technology provides biomedical technology services.
Official Site Inspections
http://www.zybt.com.tw
- Host name: 211.72.206.49
- IP address: 211.72.206.49
- Location: Taiwan
- Latitude: 23.5
- Longitude: 121
- Timezone: Asia/Taipei
More informations about "Zhengyang Biomedical Technology"
正揚生醫科技股份有限公司
「正揚生醫科技股份有限公司」是由國維牙醫診所的曾育弘董事長2004年發起，集結了國內醫界精英一起共同創立，公司組織劃分為 「生醫科技」與「Dr. Wells牙醫連鎖診所群 」兩大發展事業體。See details»
正揚生醫科技股份有限公司 - zybt.com.tw
「正揚生醫科技股份有限公司」是由國維牙醫診所的曾育弘董事長2004年發起，集結了國內醫界精英一起共同創立，公司組織劃分為 「生醫科技」與「Dr. Wells牙醫連鎖診所群 」兩大發展事業體。See details»
正扬生医科技股份有限公司 - zybt.com.tw
「正扬生医科技股份有限公司」是由国维牙医诊所的曾育弘董事长2004年发起，集结了国内医界精英一起共同创立，公司组织划分为 「生医科技」与「Dr. Wells牙医连锁诊所群 」两大发展事 …See details»
正揚生醫科技股份有限公司-環球生技月刊
Dec 17, 2021 由牙醫轉譯醫學創業家曾育弘領軍、自2005年起創辦，以集團模式發展口腔醫學、再生醫學、新藥開發三棲事業的「正揚生醫科技股份有限公司」，近期將和中研院生醫轉譯研 …See details»
ZYBT | Zhengye Biotechnology Holding Company Profile
Company profile for Zhengye Biotechnology Holding including key executives, insider trading, ownership, revenue and average growth rates. View detailed ZYBT description & address.See details»
Zheng Yang Biomedical Technology - ZoomInfo
Www.zybt.com.tw. Revenue $17.1 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is Zheng Yang …See details»
ZHENG YANG BIOMEDICAL TECHNOLOGY CO., LTD. - Dun
Find company research, competitor information, contact details & financial data for ZHENG YANG BIOMEDICAL TECHNOLOGY CO., LTD. of New Taipei City. Get the latest business insights …See details»
Zheng Yang Biomedical Technology | LinkedIn
Zheng Yang Biomedical Technology | 2 位 LinkedIn 關注者。Creating value for the customers through innovations of medical service process and treatment solutions | The company firmly …See details»
Zhengyang Biomedical Technology - Crunchbase Company Profile …
Contact Email [email protected] Phone Number +886 2 2995 0083 Zhengyang Biomedical Technology is developing and producing cutting-edge regenerative medicine applications in …See details»
ZYBT IPO News - Chinese animal health company Zhengye …
Jan 9, 2024 The Jilin, China-based company was founded in 2004 and booked $35 million in sales for the 12 months ended June 30, 2023. It plans to list on the Nasdaq under the symbol …See details»
Zhengye Biotechnology Holding Limited (ZYBT) - Stock Analysis
About ZYBT Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines …See details»
ZHENG YANG BIOMEDICAL TECHNOLOGY CO.,LTD - zybt.com.tw
The company firmly pursue the goal of quality of care, a key trusted oral health care experts. Through the comfort and safety of medical space, leading advanced medical equipment, and …See details»
Zhengye Biotechnology Holding Limited (ZYBT) Company Profile …
Zhengye Biotechnology Holding Limited (ZYBT) Zhengye Biotechnology Holding will go public soon, but the exact IPO date is still unknown. IPO Price Range. $4.00 - $5.00. Shares Offered. …See details»
ZYBT - Stock Quotes for Zhengye Biotechnology Holding Limited
Webull Financial LLC is a member of SIPC, which protects securities customers of its members up to $500,000 (including $250,000 in any cash awaiting reinvestment). An explanatory …See details»
ZYBT Statistics - Stock Analysis
ZYBT has a market cap or net worth of $212.25 million. The enterprise value is $217.22 million. Market Cap: 212.25M: Enterprise Value : 217.22M: Important Dates. Earnings Date : n/a: Ex …See details»
ZYBT | Zhengye Biotechnology Holding Financial Statements - WSJ
Zhengye Biotechnology Holding balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View ZYBT financial statements in full.See details»
ZYBT Income Statement - Stock Analysis
Dec 31, 2021 Detailed annual and quarterly income statement for Zhengye Biotechnology Holding (ZYBT). See many years of revenue, expenses and profits or losses.See details»
营收3774万美金，来自吉林的正业生物向美国证监会提交招股书， …
Jan 13, 2024 总部位于吉林省吉林市的动物疫苗制造商正业生物日前通过其在开曼的上市主体Zhengye Biotechnology Holding Limited（“正业生物”）向美国证监会提交招股说明书，拟挂牌 …See details»
ZYBT-1 - Drug Targets, Indications, Patents - Synapse
Abstract Bruton's tyrosine kinase (BTK) plays a central and pivotal role in controlling the pathways involved in the pathobiology of cancer, rheumatoid arthritis (RA), and other autoimmune …See details»
ZYBT Revenue 2021-2023 - Stock Analysis
ZYBT Revenue. Zhengye Biotechnology Holding had revenue of 253.77M CNY in the twelve months ending June 30, 2023. In the year 2022, Zhengye Biotechnology Holding had annual …See details»